Denosumab in Metabolic Bone Disease in Chronic Intestinal Failure Patients
Condition(s):Metabolic Bone DiseaseLast Updated:August 3, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Metabolic Bone DiseaseLast Updated:August 3, 2016Completed
Condition(s):Skeletal Anomalies; Kidney Transplant; ComplicationsLast Updated:February 28, 2023Completed
Condition(s):Metabolic Bone Disease; Osteopenia; Neonatal RicketsLast Updated:March 25, 2024Enrolling by invitation
Condition(s):Metabolic Bone DiseaseLast Updated:July 29, 2013Completed
Condition(s):Bone Disease, MetabolicLast Updated:December 28, 2023Not yet recruiting
Condition(s):Obesity, MorbidLast Updated:September 19, 2019Recruiting
Condition(s):Bone Diseases, MetabolicLast Updated:July 23, 2019Completed
Condition(s):Bone Diseases, MetabolicLast Updated:December 25, 2014Completed
Condition(s):Bone Disease, MetabolicLast Updated:April 14, 2008Completed
Condition(s):Bone Disease, MetabolicLast Updated:May 30, 2017Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.